{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:47Z","timestamp":1793066327712,"version":"4.5.0"},"reference-count":266,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Parkinson\u2019s disease (PD), the second most common neurodegenerative disorder worldwide, features gradual loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) along with pathological \u03b1-synuclein (\u03b1-syn) aggregation. Recently, emerging evidence has identified ferroptosis, an iron-dependent regulated cell death, as a pivotal factor in driving PD pathogenesis, with close associations to key mechanisms including \u03b1-syn protein aggregation, excessive oxidative stress, mitochondrial dysfunction, disturbances in iron metabolism, and activation of neuroinflammatory responses. This distinct mode of regulated cell death provides novel perspectives for understanding the underlying pathogenesis of PD. This review highlights the mechanisms of ferroptosis, its contribution to PD pathogenesis, evidence from animal models, and clinical advances in ferroptosis-targeted therapies. Moreover, we put forward the potential of ferroptosis in the early diagnosis and treatment of PD. A profound understanding of the ferroptosis-PD crosstalk provides a new perspective on neuronal vulnerability and holds promise for advancing novel treatments for this disabling disorder.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1709561","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:16:18Z","timestamp":1764134178000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["From pathogenesis to treatment: the emerging role of ferroptosis in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Ruoxin","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of parkinson\u2019s disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling parkinson\u2019s disease with the alpha-synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in parkinson\u2019s disease","volume":"67","author":"Dion\u00edsio","year":"2021","journal-title":"Ageing Res Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.parkreldis.2019.06.001","article-title":"Young-onset Parkinson\u2019s disease: Its unique features and their impact on quality of life","volume":"65","author":"Mehanna","year":"2019","journal-title":"Parkinsonism Related Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315985","article-title":"Dopamine dysregulation syndrome in Parkinson\u2019s disease: a systematic review of published cases","volume":"88","author":"Warren","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27372","article-title":"International parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of parkinson\u2019s disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov Disord"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.682","article-title":"Deep brain stimulation: potential for neuroprotection","volume":"6","author":"McKinnon","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","article-title":"Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides","volume":"710","author":"Ursini","year":"1982","journal-title":"Biochim Biophys Acta (BBA) - Lipids Lipid Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(89)90043-3","article-title":"Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress","volume":"2","author":"Murphy","year":"1989","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00214","article-title":"Oxytosis\/ferroptosis\u2014(re-) emerging roles for oxidative stress-dependent non-apoptotic cell death in diseases of the central nervous system","volume":"12","author":"Lewerenz","year":"2018","journal-title":"Front Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210796","article-title":"The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death","volume":"27","author":"Banjac","year":"2008","journal-title":"Oncogene"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s Disease","volume":"196","author":"Mahoney-S\u00e1nchez","year":"2021","journal-title":"Prog Neurobiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228765","article-title":"Ferroptosis mechanisms involved in neurodegenerative diseases","volume":"21","author":"Reichert","year":"2020","journal-title":"IJMS"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing parkinson\u2019s disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-0542-z","article-title":"Alpha synuclein aggregation drives ferroptosis: An interplay of iron, calcium and lipid peroxidation","volume":"27","author":"Angelova","year":"2020","journal-title":"Cell Death Differ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2010.07132.x","article-title":"The relevance of iron in the pathogenesis of Parkinson\u2019s disease","volume":"118","author":"Sian-H\u00fclsmann","year":"2011","journal-title":"J Neurochemistry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2016.05.011","article-title":"Ferroptosis, a newly characterized form of cell death in parkinson\u2019s disease that is regulated by PKC","volume":"94","author":"Do Van","year":"2016","journal-title":"Neurobiol Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23123305","article-title":"Overview on the effects of N-acetylcysteine in neurodegenerative diseases","volume":"23","author":"Tardiolo","year":"2018","journal-title":"Molecules"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e14607","DOI":"10.1111\/cns.14607","article-title":"Efficacy of the iron-chelating agent, deferiprone, in patients with parkinson\u2019s disease: a systematic review and meta-analysis","volume":"30","author":"Negida","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102063","article-title":"Research progress in the molecular mechanism of ferroptosis in parkinson\u2019s disease and regulation by natural plant products","volume":"91","author":"Yang","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0163-7827(93)90006-I","article-title":"Free radical-lipid interactions and their pathological consequences","volume":"32","author":"Rice-Evans","year":"1993","journal-title":"Prog Lipid Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S432111","article-title":"Targeting ferroptosis in bone-related diseases: facts and perspectives","volume":"16","author":"Chen","year":"2023","journal-title":"J Inflammation Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain","volume":"330","author":"Dexter","year":"1987","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","article-title":"Iron and aluminum increase in the substantia nigra of patients with parkinson\u2019s disease: an X-ray microanalysis","volume":"56","author":"Hirsch","year":"1991","journal-title":"J Neurochem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab084","article-title":"Regional brain iron and gene expression provide insights into neurodegeneration in parkinson\u2019s disease","volume":"144","author":"Thomas","year":"2021","journal-title":"Brain"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13208","article-title":"Motor associations of iron accumulation in deep grey matter nuclei in parkinson\u2019s disease: A cross-sectional study of iron-related magnetic resonance imaging susceptibility","volume":"24","author":"Martin-Bastida","year":"2017","journal-title":"Eur J Neurol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2018.07.009","article-title":"A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells","volume":"53","author":"El Hout","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41420-025-02696-2","article-title":"Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications","volume":"11","author":"Zhao","year":"2025","journal-title":"Cell Death Discov"},{"key":"B41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.physiol.69.031905.164337","article-title":"Iron homeostasis","volume":"69","author":"Andrews","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin receptor is a specific ferroptosis marker","volume":"30","author":"Feng","year":"2020","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.02.009","article-title":"A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in parkinson\u2019s disease","volume":"34","author":"Mastroberardino","year":"2009","journal-title":"Neurobiol Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2023.09.004","article-title":"TFEB regulates cellular labile iron and prevents ferroptosis in a TfR1-dependent manner","volume":"208","author":"Chen","year":"2023","journal-title":"Free Radical Biol Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1634516","article-title":"Ferroptosis and bone health: bridging the gap between mechanisms and therapy","volume":"16","author":"Xiao","year":"2025","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of parkinson\u2019s disease","volume":"105","author":"Salazar","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/biom13081172","article-title":"Membrane transporters involved in iron trafficking: physiological and pathological aspects","volume":"13","author":"Pasquadibisceglie","year":"2023","journal-title":"Biomolecules"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9961628","article-title":"Ferritinophagy-mediated ferroptosis involved in paraquat-induced neurotoxicity of dopaminergic neurons: implication for neurotoxicity in PD","volume":"2021","author":"Zuo","year":"2021","journal-title":"Oxid Med Cell Longevity"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.02.005","article-title":"Cellular iron: ferroportin is the only way out","volume":"1","author":"Ganz","year":"2005","journal-title":"Cell Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8684130","article-title":"Hepcidin plays a key role in 6-OHDA induced iron overload and apoptotic cell death in a cell culture model of parkinson\u2019s disease","volume":"2016","author":"Xu","year":"2016","journal-title":"Parkinson\u2019s Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301988200","article-title":"Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system","volume":"278","author":"Jeong","year":"2003","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1485523","article-title":"Unveiling ferroptosis: a new frontier in skin disease research","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Ann Neurol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.3768-11.2011","article-title":"Ceruloplasmin oxidation, a feature of parkinson\u2019s disease CSF, inhibits ferroxidase activity and promotes cellular iron retention","volume":"31","author":"Olivieri","year":"2011","journal-title":"J Neurosci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00124","article-title":"The physiological functions of iron regulatory proteins in iron homeostasis - an update","volume":"5","author":"Zhang","year":"2014","journal-title":"Front Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2024.06.020","article-title":"The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in parkinson\u2019s disease","volume":"222","author":"Yao","year":"2024","journal-title":"Free Radical Biol Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00401-008-0361-7","article-title":"Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for parkinson\u2019s disease","volume":"116","author":"Zecca","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13237","article-title":"Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the","volume":"135","author":"Wakamatsu","year":"2015","journal-title":"locus coeruleus J Neurochem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41531-018-0050-8","article-title":"Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in parkinson\u2019s disease","volume":"4","author":"Zucca","year":"2018","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2023.102414","article-title":"DOPA pheomelanin is increased in nigral neuromelanin of parkinson\u2019s disease","volume":"223","author":"Cai","year":"2023","journal-title":"Prog Neurobiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in parkinson\u2019s disease pathogenesis","volume":"10","author":"Carballo-Carbajal","year":"2019","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27776","article-title":"Neuromelanin, aging, and neuronal vulnerability in parkinson\u2019s disease","volume":"34","author":"Vila","year":"2019","journal-title":"Mov Disord"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad331","article-title":"Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates","volume":"146","author":"Chocarro","year":"2023","journal-title":"Brain"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9317","article-title":"Brain lipidomics: from functional landscape to clinical significance","volume":"8","author":"Yoon","year":"2022","journal-title":"Sci Adv"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.12.086","article-title":"ACSL4 and the lipoxygenases 15\/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons","volume":"195","author":"Bouchaoui","year":"2023","journal-title":"Free Radical Biol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat Chem Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1159\/000538106","article-title":"A deep insight into ferroptosis in renal disease: facts and perspectives","volume":"10","author":"Han","year":"2024","journal-title":"Kidney Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.5b00245","article-title":"Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death","volume":"10","author":"Dixon","year":"2015","journal-title":"ACS Chem Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2239","article-title":"Acsl4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat Chem Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2022.11.018","article-title":"Ketone body \u03b2-hydroxybutyric acid ameliorates dopaminergic neuron injury through modulating zinc finger protein 36\/acyl-CoA synthetase long-chain family member four signaling axis-mediated ferroptosis","volume":"509","author":"Yu","year":"2023","journal-title":"Neuroscience"},{"key":"B77","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","article-title":"PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals","volume":"171","author":"Wenzel","year":"2017","journal-title":"Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.plipres.2018.09.002","article-title":"The evolutionary hypothesis of reaction specificity of mammalian ALOX15 orthologs","volume":"72","author":"Kuhn","year":"2018","journal-title":"Prog Lipid Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.8b09913","article-title":"Empowerment of 15-lipoxygenase catalytic competence in selective oxidation of membrane ETE-PE to ferroptotic death signals, HpETE-PE","volume":"140","author":"Anthonymuthu","year":"2018","journal-title":"J Am Chem Soc"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99490","article-title":"Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium","volume":"128","author":"Dar","year":"2018","journal-title":"J Clin Invest"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e0309893","DOI":"10.1371\/journal.pone.0309893","article-title":"Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of parkinson\u2019s disease","volume":"19","author":"Minnella","year":"2024","journal-title":"PloS One"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.10.490","article-title":"Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders","volume":"111","author":"Di Domenico","year":"2017","journal-title":"Free Radical Biol Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/HM9.0000000000000094","article-title":"Acupuncture for ischemic stroke: where are we now","volume":"4","author":"Zhu","year":"2024","journal-title":"Acupunct Herb Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e2006203","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: how does lipid peroxidation cause ferroptosis","volume":"16","author":"Feng","year":"2018","journal-title":"PloS Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid Med Cell Longevity"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.12.046","article-title":"Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal","volume":"111","author":"Romano","year":"2017","journal-title":"Free Radical Biol Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in parkinson\u2019s disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2233906","article-title":"Oxidative stress and 4-hydroxy-2-nonenal (4-HNE): implications in the pathogenesis and treatment of aging-related diseases","volume":"2022","author":"Li","year":"2022","journal-title":"J Immunol Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2016.02.011","article-title":"Highly specific changes in antioxidant levels and lipid peroxidation in parkinson\u2019s disease and its progression: disease and staging biomarkers and new drug targets","volume":"617","author":"De Farias","year":"2016","journal-title":"Neurosci Lett"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.4c00348","article-title":"Malondialdehyde mediated alpha-synuclein aggregation: A plausible etiology of parkinson\u2019s disease in oxidative stress","volume":"38","author":"Thakkar","year":"2025","journal-title":"Chem Res Toxicol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/s41467-020-15065-7","article-title":"Analysis of DNA methylation associates the cystine\u2013glutamate antiporter SLC7A11 with risk of parkinson\u2019s disease","volume":"11","author":"Vallerga","year":"2020","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1097\/HM9.0000000000000120","article-title":"The hemerocallis citrina extracts ameliorate radiation-induced ferroptosis in LO2 cells through the Nrf2-xCT\/GPX4 pathway","volume":"4","author":"Zhu","year":"2024","journal-title":"Acupunct Herb Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233829","article-title":"Iron brain menace: the involvement of ferroptosis in parkinson disease","volume":"11","author":"Lin","year":"2022","journal-title":"Cells"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-8","article-title":"Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of parkinson\u2019s brain","volume":"6","author":"Bellinger","year":"2011","journal-title":"Mol Neurodegener"},{"key":"B95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neulet.2008.12.053","article-title":"Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic parkinson disease","volume":"452","author":"Blackinton","year":"2009","journal-title":"Neurosci Lett"},{"key":"B96","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12964-025-02121-2","article-title":"From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders","volume":"23","author":"He","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440309","article-title":"Ferroptosis: a novel mechanism of cell death in ophthalmic conditions","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.03.023","article-title":"Coenzyme Q10 deficiency in patients with parkinson\u2019s disease","volume":"318","author":"Mischley","year":"2012","journal-title":"J Neurol Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11010002","article-title":"Coenzyme Q10, ageing and the nervous system: an overview","volume":"11","author":"Mantle","year":"2021","journal-title":"Antioxidants"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2011.3960","article-title":"NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in parkinson\u2019s disease","volume":"16","author":"Choi","year":"2012","journal-title":"Antioxid Redox Signaling"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-015-0189-z","article-title":"Loss of angiotensin II receptor expression in dopamine neurons in parkinson\u2019s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation","volume":"3","author":"Zawada","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"B104","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent Sci"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-211-73574-9_14","article-title":"Biochemistry of postmortem brains in parkinson\u2019s disease: historical overview and future prospects","volume":"75","author":"Nagatsu","year":"2007","journal-title":"Neuropsychiatr Disord an Integr Approach"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2022.09.018","article-title":"Revealing a novel contributing landscape of ferroptosis-related genes in parkinson\u2019s disease","volume":"20","author":"Jian","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/nature05859","article-title":"RAS\u2013RAF\u2013MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1509172","article-title":"Decoding ferroptosis: transforming orthopedic disease management","volume":"15","author":"Huo","year":"2024","journal-title":"Front Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e132747","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.08.034","article-title":"CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.06.018","article-title":"CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer","volume":"432","author":"Kim","year":"2018","journal-title":"Cancer Lett"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e2121987119","DOI":"10.1073\/pnas.2121987119","article-title":"A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria","volume":"119","author":"Wu","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1424954","article-title":"Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.698679","article-title":"STING1 promotes ferroptosis through MFN1\/2-dependent mitochondrial fusion","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23568","article-title":"Somatic mitochondrial DNA mutations in early parkinson and incidental lewy body disease","volume":"71","author":"Lin","year":"2012","journal-title":"Ann Neurol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.1085","article-title":"The impact of aging on neurological diseases in the elderly: molecular mechanisms and therapeutic perspectives","volume":"16","author":"Zhou","year":"2025","journal-title":"Aging Dis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-022-01265-w","article-title":"Targeting mitochondria as a therapeutic approach for parkinson\u2019s disease","volume":"43","author":"Abrishamdar","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww022","article-title":"Iron and dopamine: a toxic couple","volume":"139","author":"Hare","year":"2016","journal-title":"Brain"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1038\/s41467-024-47867-4","article-title":"Mitochondrial complex I deficiency stratifies idiopathic parkinson\u2019s disease","volume":"15","author":"Fl\u00f8nes","year":"2024","journal-title":"Nat Commun"},{"key":"B122","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1038\/ncomms6244","article-title":"Drp1 inhibition attenuates neurotoxicity and dopamine release deficits","volume":"5","author":"Rappold","year":"2014","journal-title":"vivo Nat Commun"},{"key":"B123","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1038\/s41598-017-07181-0","article-title":"Mitochondrial division inhibitor-1 is neuroprotective in the A53T-\u03b1-synuclein rat model of parkinson\u2019s disease","volume":"7","author":"Bido","year":"2017","journal-title":"Sci Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.09.010","article-title":"Parkinson\u2019s disease: connecting mitochondria to inflammasomes","volume":"43","author":"Lawrence","year":"2022","journal-title":"Trends Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson\u2019s disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105920","article-title":"Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in parkinson\u2019s disease and neurodegeneration with brain iron accumulation disorders","volume":"175","author":"Wise","year":"2022","journal-title":"Neurobiol Dis"},{"key":"B127","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bcp.2017.12.001","article-title":"Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages","volume":"148","author":"Dichtl","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and parkinson\u2019s disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog Neurobiol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.10.099","article-title":"Antiferroptotic activity of non-oxidative dopamine","volume":"480","author":"Wang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B130","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-synuclein misfolding and aggregation: implications in parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim Biophys Acta (BBA) - Proteins Proteom"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2009.11.005","article-title":"Binding of \u03b1-synuclein with fe(III) and with fe(II) and biological implications of the resultant complexes","volume":"104","author":"Peng","year":"2010","journal-title":"J Inorg Biochem"},{"key":"B132","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s10020-025-01208-3","article-title":"The interplay of iron, oxidative stress, and \u03b1-synuclein in parkinson\u2019s disease progression","volume":"31","author":"Chen","year":"2025","journal-title":"Mol Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41531-021-00218-2","article-title":"Exploring human-genome gut-microbiome interaction in parkinson\u2019s disease","volume":"7","author":"Wallen","year":"2021","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2019.06.024","article-title":"Interactions between iron and \u03b1-synuclein pathology in parkinson\u2019s disease","volume":"141","author":"Chen","year":"2019","journal-title":"Free Radical Biol Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human \u03b1-synuclein","volume":"276","author":"Uversky","year":"2001","journal-title":"J Biol Chem"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2017.08.001","article-title":"Alpha-synuclein ferrireductase activity is detectible in vivo, is altered in parkinson\u2019s disease and increases the neurotoxicity of DOPAL","volume":"85","author":"McDowall","year":"2017","journal-title":"Mol Cell Neurosci"},{"key":"B137","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00018-022-04389-w","article-title":"Restricting \u03b1-synuclein transport into mitochondria by inhibition of \u03b1-synuclein\u2013VDAC complexation as a potential therapeutic target for parkinson\u2019s disease treatment","volume":"79","author":"Rajendran","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713270","article-title":"The bidirectional interplay of \u03b1-synuclein with lipids in the central nervous system and its implications for the pathogenesis of parkinson\u2019s disease","volume":"24","author":"Battis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for parkinson treatment","volume":"73","author":"Fanning","year":"2019","journal-title":"Mol Cell"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111231","article-title":"Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition","volume":"40","author":"Mahoney-Sanchez","year":"2022","journal-title":"Cell Rep"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14713","article-title":"Antibodies against alpha-synuclein: tools and therapies","volume":"150","author":"Vaikath","year":"2019","journal-title":"J Neurochem"},{"key":"B142","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00018-022-04240-2","article-title":"Initiation and progression of \u03b1-synuclein pathology in parkinson\u2019s disease","volume":"79","author":"Tofaris","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020283","article-title":"Interaction between parkin and \u03b1-synuclein in PARK2-mediated parkinson\u2019s disease","volume":"10","author":"Madsen","year":"2021","journal-title":"Cells"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"B145","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm3028","article-title":"Mechanisms of mitophagy","volume":"12","author":"Youle","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061505","article-title":"Ferroptosis and cancer: mitochondria meet the \u201ciron maiden\u201d cell death","volume":"9","author":"Battaglia","year":"2020","journal-title":"Cells"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.419721","article-title":"Voltage-dependent anion channels (VDACs) recruit parkin to defective mitochondria to promote mitochondrial autophagy","volume":"287","author":"Sun","year":"2012","journal-title":"J Biol Chem"},{"key":"B148","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41419-022-04770-4","article-title":"Mitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/6739691","article-title":"Inhibition of VDAC1 rescues A\u03b21-42-induced mitochondrial dysfunction and ferroptosis via activation of AMPK and wnt\/\u03b2-catenin pathways","volume":"2023","author":"Zhou","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.12.027","article-title":"Parkin inhibits iron overload-induced cardiomyocyte ferroptosis by ubiquitinating ACSL4 and modulating PUFA-phospholipids metabolism","volume":"15","author":"Xiao","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03111-7","article-title":"Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms","volume":"76","author":"Oksanen","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol Dis"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23337","article-title":"Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop","volume":"66","author":"Mouton-Liger","year":"2018","journal-title":"Glia"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1007\/s12035-018-1264-9","article-title":"Loss of microglial parkin inhibits necroptosis and contributes to neuroinflammation","volume":"56","author":"Dion\u00edsio","year":"2019","journal-title":"Mol Neurobiol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23482","article-title":"Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation","volume":"66","author":"Singh","year":"2018","journal-title":"Glia"},{"key":"B156","doi-asserted-by":"publisher","first-page":"a011338","DOI":"10.1101\/cshperspect.a011338","article-title":"Mitochondrial quality control mediated by PINK1 and parkin: links to parkinsonism","volume":"4","author":"Narendra","year":"2012","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41467-020-15109-y","article-title":"DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase","volume":"11","author":"Cao","year":"2020","journal-title":"Nat Commun"},{"key":"B158","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jnc.14471","article-title":"Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration","volume":"147","author":"Audano","year":"2018","journal-title":"J Neurochem"},{"key":"B159","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nbd.2008.09.013","article-title":"DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone","volume":"33","author":"Mullett","year":"2009","journal-title":"Neurobiol Dis"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101508","article-title":"Mitochondrial dysfunction, protein misfolding and neuroinflammation in parkinson\u2019s disease: roads to biomarker discovery","volume":"11","author":"Picca","year":"2021","journal-title":"Biomolecules"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02291-8","article-title":"LRRK2 Mediates \u03b1-Synuclein-Induced Neuroinflammation and Ferroptosis through the p62-Keap1-Nrf2 Pathway in Parkinson\u2019s Disease","volume":"48","author":"Liu","year":"2025","journal-title":"Inflammation"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31250","article-title":"LRRK2 regulates ferroptosis through the system xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of parkinson\u2019s disease","volume":"239","author":"Zheng","year":"2024","journal-title":"J Cell Physiol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043709","article-title":"The relationship between iron and LRRK2 in a 6-OHDA-induced parkinson\u2019s disease model","volume":"24","author":"Jia","year":"2023","journal-title":"IJMS"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00267","article-title":"Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases","volume":"14","author":"Song","year":"2020","journal-title":"Front Neurosci"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7176","article-title":"The roles of NRF2 in modulating cellular iron homeostasis","volume":"29","author":"Kerins","year":"2018","journal-title":"Antioxid Redox Signaling"},{"key":"B167","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molcel.2017.09.009","article-title":"NRF2 is a major target of ARF in p53-independent tumor suppression","volume":"68","author":"Chen","year":"2017","journal-title":"Mol Cell"},{"key":"B168","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/toxsci\/kfr183","article-title":"Beneficial role of Nrf2 in regulating NADPH generation and consumption","volume":"123","author":"Wu","year":"2011","journal-title":"Toxicol Sci"},{"key":"B169","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41420-023-01690-w","article-title":"Exogenous H2S initiating Nrf2\/GPx4\/GSH pathway through promoting Syvn1-Keap1 interaction in diabetic hearts","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.787258","article-title":"A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in alzheimer\u2019s and parkinson\u2019s diseases","volume":"15","author":"Saha","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"B171","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41420-022-01063-9","article-title":"Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity","volume":"8","author":"Cao","year":"2022","journal-title":"Cell Death Discov"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.7b00287","article-title":"MitoNEET (CISD1) knockout mice show signs of striatal mitochondrial dysfunction and a parkinson\u2019s disease phenotype","volume":"8","author":"Geldenhuys","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"B173","doi-asserted-by":"publisher","first-page":"e97027","DOI":"10.7554\/eLife.97027","article-title":"Iron-sulfur cluster loss in mitochondrial CISD1 mediates PINK1 loss-of-function phenotypes","volume":"13","author":"Bitar","year":"2024","journal-title":"Elife"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-019-0482-7","article-title":"Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Death Differ"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa028","article-title":"CHCHD2 harboring parkinson\u2019s disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2","volume":"29","author":"Cornelissen","year":"2020","journal-title":"Hum Mol Genet"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15500","article-title":"Loss of parkinson\u2019s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c","volume":"8","author":"Meng","year":"2017","journal-title":"Nat Commun"},{"key":"B177","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jnc.13593","article-title":"Genetics in parkinson disease: mendelian versus non-mendelian inheritance","volume":"139","author":"Hernandez","year":"2016","journal-title":"J Neurochem"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071006","article-title":"The genetics of parkinson\u2019s disease and implications for clinical practice","volume":"12","author":"Day","year":"2021","journal-title":"Genes"},{"key":"B179","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuro.2021.11.003","article-title":"Mitochondrial iron metabolism and neurodegenerative diseases","volume":"88","author":"Cheng","year":"2022","journal-title":"Neurotoxicology"},{"key":"B180","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neuron.2017.01.019","article-title":"Parkinson sac domain mutation in synaptojanin 1 impairs clathrin uncoating at synapses and triggers dystrophic changes in dopaminergic axons","volume":"93","author":"Cao","year":"2017","journal-title":"Neuron"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22373","article-title":"Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism","volume":"34","author":"Quadri","year":"2013","journal-title":"Hum Mutat"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.581191","article-title":"Chemically induced models of parkinson\u2019s disease: history and perspectives for the involvement of ferroptosis","volume":"14","author":"Wen","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-023-01382-4","article-title":"Inhibition of ACSL4 alleviates parkinsonism phenotypes by reduction of lipid reactive oxygen species","volume":"20","author":"Tang","year":"2023","journal-title":"Neurotherapeutics"},{"key":"B184","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12906-023-03967-0","article-title":"Neuroprotective effects of morroniside from cornus officinalis sieb. Et zucc against parkinson\u2019s disease via inhibiting oxidative stress and ferroptosis","volume":"23","author":"Li","year":"2023","journal-title":"BMC Complementary Med Ther"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-020-02049-3","article-title":"Activation of p62-Keap1-Nrf2 pathway protects 6-hydroxydopamine-induced ferroptosis in dopaminergic cells","volume":"57","author":"Sun","year":"2020","journal-title":"Mol Neurobiol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-025-00693-7","article-title":"Ferrous sulfate and lipopolysaccharide co-exposure induce neuroinflammation, neurobehavioral motor deficits, neurodegenerative and histopathological biomarkers relevant to Parkinson\u2019s disease-like symptoms in Wistar rats","volume":"38","author":"Pandey","year":"2025","journal-title":"Biometals"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04824-6","article-title":"ROS regulate rotenone-induced SH-SY5Y dopamine neuron death through ferroptosis-mediated autophagy and apoptosis","volume":"62","author":"Li","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/00207454.2021.1885403","article-title":"A novel treatment strategy to prevent parkinson\u2019s disease: Focus on iron regulatory protein 1 (IRP1)","volume":"133","author":"Berry","year":"2023","journal-title":"Int J Neurosci"},{"key":"B189","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1742-2094-8-163","article-title":"Differential regional expression patterns of \u03b1-synuclein, TNF-\u03b1, and IL-1\u03b2; and variable status of dopaminergic neurotoxicity in mouse brain after paraquat treatment","volume":"8","author":"Mitra","year":"2011","journal-title":"J Neuroinflamm"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.03.015","article-title":"Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in parkinson\u2019s disease","volume":"152","author":"Zhang","year":"2020","journal-title":"Free Radical Biol Med"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23338","article-title":"Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of parkinson\u2019s disease","volume":"66","author":"Castro-S\u00e1nchez","year":"2018","journal-title":"Glia"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1403215111","article-title":"Abrogation of \u03b1-synuclein\u2013mediated dopaminergic neurodegeneration in LRRK2-deficient rats","volume":"111","author":"Daher","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B193","doi-asserted-by":"publisher","first-page":"e34693","DOI":"10.1371\/journal.pone.0034693","article-title":"Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia","volume":"7","author":"Kim","year":"2012","journal-title":"PloS One"},{"key":"B194","doi-asserted-by":"publisher","first-page":"e3001480","DOI":"10.1371\/journal.pbio.3001480","article-title":"Mutations in LRRK2 linked to parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia","volume":"19","author":"Mamais","year":"2021","journal-title":"PloS Biol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12868-016-0315-2","article-title":"Leucine-rich repeat kinase 2 (LRRK2) regulates \u03b1-synuclein clearance in microglia","volume":"17","author":"Maekawa","year":"2016","journal-title":"BMC Neurosci"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8927-y","article-title":"Early expression of parkinson\u2019s disease-related mitochondrial abnormalities in PINK1 knockout rats","volume":"53","author":"Villeneuve","year":"2016","journal-title":"Mol Neurobiol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102229","article-title":"Systematic surveys of iron homeostasis mechanisms reveal ferritin superfamily and nucleotide surveillance regulation to be modified by PINK1 absence","volume":"9","author":"Key","year":"2020","journal-title":"Cells"},{"key":"B198","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in parkinson\u2019s disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid Redox Signaling"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in parkinson\u2019s disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci Rep"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of deferiprone in parkinson\u2019s disease","volume":"387","author":"Devos","year":"2022","journal-title":"N Engl J Med"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1548","article-title":"N-acetyl cysteine is associated with dopaminergic improvement in parkinson\u2019s disease","volume":"106","author":"Monti","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1008","article-title":"Repeated-dose oral N-acetylcysteine in parkinson\u2019s disease: pharmacokinetics and effect on brain glutathione and oxidative stress","volume":"58","author":"Coles","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22401","article-title":"Randomized, double-blind, pilot evaluation of intravenous glutathione in parkinson\u2019s disease","volume":"24","author":"Hauser","year":"2009","journal-title":"Mov Disord"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26351","article-title":"A randomized, double-blind phase I\/IIa study of intranasal glutathione in parkinson\u2019s disease: PHASE I\/IIA (IN)GSH IN PD","volume":"30","author":"Mischley","year":"2015","journal-title":"Mov Disord"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-161040","article-title":"Phase IIb study of intranasal glutathione in parkinson\u2019s disease","volume":"7","author":"Mischley","year":"2017","journal-title":"J Parkinson\u2019s Dis"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch Neurol"},{"key":"B207","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A randomized clinical trial of high-dosage coenzyme Q10 in early parkinson disease: No evidence of benefit","volume":"71","author":"Beal","year":"2014","journal-title":"JAMA Neurol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5801","article-title":"Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in parkinson\u2019s disease","volume":"21","author":"Seet","year":"2014","journal-title":"Antioxid Redox Signaling"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.05.022","article-title":"Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for parkinson\u2019s disease","volume":"21","author":"Yoritaka","year":"2015","journal-title":"Park Relat Disord"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2017.03.014","article-title":"The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"108","author":"Taghizadeh","year":"2017","journal-title":"Neurochemistry Int"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14881","article-title":"CuII (atsm) inhibits ferroptosis: implications for treatment of neurodegenerative disease","volume":"177","author":"Southon","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2021.07.016","article-title":"Restoring lost nigrostriatal fibers in parkinson\u2019s disease based on clinically-inspired design criteria","volume":"175","author":"Gordi\u00e1n-V\u00e9lez","year":"2021","journal-title":"Brain Res Bull"},{"key":"B213","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1148\/radiology.177.1.2399339","article-title":"Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths","volume":"177","author":"Bizzi","year":"1990","journal-title":"Radiology"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203341","article-title":"Imaging the substantia nigra in parkinson disease and other parkinsonian syndromes","volume":"300","author":"Bae","year":"2021","journal-title":"Radiology"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-013-1171-8","article-title":"3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of parkinson\u2019s disease","volume":"55","author":"Ogisu","year":"2013","journal-title":"Neuroradiology"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20180037","article-title":"Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage parkinson\u2019s disease","volume":"91","author":"Takahashi","year":"2018","journal-title":"Br J Radiol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26417","article-title":"Quantitative susceptibility mapping of the midbrain in parkinson\u2019s disease: nigral iron in PD","volume":"31","author":"Du","year":"2016","journal-title":"Mov Disord"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25015","article-title":"Magnetic resonance imaging of the substantia nigra in parkinson\u2019s disease","volume":"27","author":"Leh\u00e9ricy","year":"2012","journal-title":"Movement Disord"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25491","article-title":"Diffusion tensor imaging of parkinson\u2019s disease, atypical parkinsonism, and essential tremor","volume":"28","author":"Prodoehl","year":"2013","journal-title":"Mov Disord"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0447-5","article-title":"In vivo detection of iron and neuromelanin by transcranial sonography \u2013 a new approach for early detection of substantia nigra damage","volume":"113","author":"Berg","year":"2006","journal-title":"J Neural Transm"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001503","article-title":"Transcranial sonography in differential diagnosis of parkinson disease and other movement disorders","volume":"134","author":"Wang","year":"2021","journal-title":"Chin Med J"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1159\/000237221","article-title":"8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases","volume":"6","author":"Gmitterov\u00e1","year":"2009","journal-title":"Neurodegener Dis"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.11.065","article-title":"Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2\u2032-deoxyguanosine in the cerebrospinal fluid of patients with living parkinson\u2019s disease demonstrate that mitochondrial oxidative damage and\/or oxidative DNA damage contributes to the neurodegenerative process","volume":"469","author":"Isobe","year":"2010","journal-title":"Neurosci Lett"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01499-6","article-title":"Epigenetic regulation of iron metabolism and ferroptosis in parkinson\u2019s disease: identifying novel epigenetic targets","volume":"46","author":"Gao","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3390\/ph14020095","article-title":"Mechanisms of intranasal deferoxamine in neurodegenerative and neurovascular disease","volume":"14","author":"Kosyakovsky","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409329","article-title":"Targeting the labile iron pool with engineered DFO nanosheets to inhibit ferroptosis for parkinson\u2019s disease therapy","volume":"36","author":"Lei","year":"2024","journal-title":"Adv Mater"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.918292","article-title":"Therapeutic effect of ultrasound combined with porous lipid clioquinol\/PLGA microbubbles on ferroptosis in HL-1 cardiac cell induced by isoproterenol attack","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103225","article-title":"Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of parkinson\u2019s disease through AKT\/mTOR pathway","volume":"12","author":"Shi","year":"2020","journal-title":"Aging (Milano)"},{"key":"B229","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40478-017-0456-2","article-title":"The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of parkinson\u2019s disease","volume":"5","author":"Finkelstein","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313042","article-title":"Targeting ferroptosis in parkinson\u2019s disease: mechanisms and emerging therapeutic strategies","volume":"25","author":"Zhou","year":"2024","journal-title":"IJMS"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02826-y","article-title":"Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants","volume":"94","author":"Gutbier","year":"2020","journal-title":"Arch Toxicol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25356","article-title":"N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice","volume":"84","author":"Karuppagounder","year":"2018","journal-title":"Ann Neurol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"e0157602","DOI":"10.1371\/journal.pone.0157602","article-title":"N-acetyl cysteine may support dopamine neurons in parkinson\u2019s disease: preliminary clinical and cell line data","volume":"11","author":"Monti","year":"2016","journal-title":"PloS One"},{"key":"B234","doi-asserted-by":"publisher","first-page":"e85115","DOI":"10.1371\/journal.pone.0085115","article-title":"Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity","volume":"9","author":"Sripetchwandee","year":"2014","journal-title":"PloS One"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9070600","article-title":"N-acetylcysteine nanocarriers protect against oxidative stress in a cellular model of parkinson\u2019s disease","volume":"9","author":"Mursaleen","year":"2020","journal-title":"Antioxidants"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10030453","article-title":"Antioxidant therapeutics in parkinson\u2019s disease: current challenges and opportunities","volume":"10","author":"Duarte-Jurado","year":"2021","journal-title":"Antioxidants"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050799","article-title":"Selenium and selenoproteins in health","volume":"13","author":"Zhang","year":"2023","journal-title":"Biomolecules"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13030298","article-title":"Antioxidant systems as modulators of ferroptosis: focus on transcription factors","volume":"13","author":"Punziano","year":"2024","journal-title":"Antioxidants"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2010.06.020","article-title":"Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice","volume":"57","author":"Khan","year":"2010","journal-title":"Neurochem Int"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2014.07.004","article-title":"Selenium reduces bradykinesia and DNA damage in a rat model of parkinson\u2019s disease","volume":"31","author":"Ellwanger","year":"2015","journal-title":"Nutrition"},{"key":"B241","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1038\/s41598-020-66493-w","article-title":"Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a parkinson\u2019s disease rat model","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112285","article-title":"The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of parkinson\u2019s disease","volume":"209","author":"Hung","year":"2012","journal-title":"J Exp Med"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-018-2676-6","article-title":"Carnosine protects cardiac myocytes against lipid peroxidation products","volume":"51","author":"Zhao","year":"2019","journal-title":"Amino Acids"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1089\/rej.2008.0716","article-title":"Carnisone increases efficiency of DOPA therapy of parkinson\u2019s disease: a pilot study","volume":"11","author":"Boldyrev","year":"2008","journal-title":"Rejuvenation Res"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biol"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5463134","article-title":"Sorting nexin 5 plays an important role in promoting ferroptosis in parkinson\u2019s disease","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J Am Chem Soc"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1415518111","article-title":"Synchronized renal tubular cell death involves ferroptosis","volume":"111","author":"Linkermann","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-020-00620-5","article-title":"Selective ferroptosis inhibitor liproxstatin-1 attenuates neurological deficits and neuroinflammation after subarachnoid hemorrhage","volume":"37","author":"Cao","year":"2021","journal-title":"Neurosci Bull"},{"key":"B250","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","article-title":"The mechanism of ferroptosis and its related diseases","volume":"4","author":"Feng","year":"2023","journal-title":"Mol BioMed"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03679-5","article-title":"New inhibitor targeting acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis","volume":"78","author":"Castillo","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.2c00317","article-title":"LPCAT3 inhibitors remodel the polyunsaturated phospholipid content of human cells and protect from ferroptosis","volume":"17","author":"Reed","year":"2022","journal-title":"ACS Chem Biol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106779","article-title":"ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis","volume":"193","author":"Li","year":"2023","journal-title":"Pharmacol Res"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-020-00734-x","article-title":"Phospholipase iPLA2\u03b2 averts ferroptosis by eliminating a redox lipid death signal","volume":"17","author":"Sun","year":"2021","journal-title":"Nat Chem Biol"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107114","article-title":"Unveiling the role of iPLA2\u03b2 in neurodegeneration: From molecular mechanisms to advanced therapies","volume":"202","author":"Liu","year":"2024","journal-title":"Pharmacol Res"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-012-1238-2","article-title":"Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of parkinson\u2019s disease","volume":"28","author":"Du","year":"2012","journal-title":"Neurosci Bull"},{"key":"B257","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4236\/cellbio.2013.22005","article-title":"Protective effects of flavonoid baicalein against menadione-induced damage in SK-N-MC cells","volume":"2","author":"Moslehi","year":"2013","journal-title":"Cellbio"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7769355","article-title":"Quercetin protects against MPP+ \/MPTP-induced dopaminergic neuron death in parkinson\u2019s disease by inhibiting ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2022.102103","article-title":"The neuroprotective effects of paeoniflorin against MPP+-induced damage to dopaminergic neurons via the akt\/Nrf2\/GPX4 pathway","volume":"122","author":"Wang","year":"2022","journal-title":"J Chem Neuroanat"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1039\/D2FO00357K","article-title":"Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1\u2013Nrf2 protein\u2013protein interaction from penthorum chinense pursh. attenuates 6-hydroxydopamine-induced ferroptosis in zebrafish and dopaminergic neurons","volume":"13","author":"Sun","year":"2022","journal-title":"Food Funct"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.08.011","article-title":"Hinokitiol functions as a ferroptosis inhibitor to confer neuroprotection","volume":"190","author":"Xi","year":"2022","journal-title":"Free Radical Biol Med"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29884","article-title":"Targeting glucagon-like peptide 1 signaling: a potential disease modifying therapy for parkinson\u2019s disease","volume":"39","author":"Kimura","year":"2024","journal-title":"Mov Disord"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3390\/nu14224886","article-title":"Neurotrophic role of the next-generation probiotic strain L. lactis MG1363-pMG36e-GLP-1 on parkinson\u2019s disease via inhibiting ferroptosis","volume":"14","author":"Yue","year":"2022","journal-title":"Nutrients"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01792-4","article-title":"Incretin and insulin signaling as novel therapeutic targets for alzheimer\u2019s and parkinson\u2019s disease","volume":"28","author":"Nowell","year":"2023","journal-title":"Mol Psychiatry"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of lixisenatide in early parkinson\u2019s disease","volume":"390","author":"Meissner","year":"2024","journal-title":"N Engl J Med"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175875","article-title":"Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: potential repurposing of anti-cancer drug as a disease-modifying agent in parkinson\u2019s disease","volume":"954","author":"Mansour","year":"2023","journal-title":"Eur J Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1709561\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:16:20Z","timestamp":1764134180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1709561\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":266,"alternative-id":["10.3389\/fimmu.2025.1709561"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1709561","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1709561"}}